News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Victory Capital, overseeing the RS Large Cap Value Strategy, released its Q2 2026 investor letter. A copy of the letter can be downloaded here. The RS Large Cap Value Strategy underperformed the Russell 1000 Value Index in the second quarter of 2026 as unfavorable …
Sharemaestro market context Trend signal active 52 weeks +20.8%VSE Corporation has announced its second-quarter 2026 results conference call will take place on Thursday, July 23, 2026, at 8:30 AM ET. The company plans to release its financial results after market close on Wednesday, July 22, 2026. Interested parties can access the call …
This article focuses on the enterprise value to EBITDA forward for Kyivstar Group Ltd., traded on NASDAQ under the symbol KYIVW. It appears to be a stub or a section heading within a larger financial data platform, highlighting a specific financial metric for the …
VSee Health, Inc. has announced a proposed reverse stock split of up to 80-for-1 to maintain its Nasdaq listing. This decision, which is subject to shareholder and regulatory approval, follows the termination of a previous equity purchase agreement and a reduction from an earlier …
VSee Health, Inc. has reaffirmed its commitment to minimizing shareholder dilution and maintaining its Nasdaq listing. The company announced a proposed maximum 80-for-1 reverse stock split, significantly reduced from a previously considered 250-to-1 ratio, and confirmed the termination of a standby equity purchase agreement. …
VSee Health (NASDAQ:VSEE) announced the termination of its standby equity purchase agreement, eliminating expectations of near-term dilution, and reaffirmed its commitment to minimizing shareholder dilution. The company's board also approved a proposed reverse stock split of up to 80-for-1, down from a previously referenced …
Bessemer Group Inc. significantly increased its stake in CVS Health Corporation during the first quarter, while company insiders like director Larry Robbins and EVP Tilak Mandadi reduced their holdings. Wall Street analysts maintain a "Moderate Buy" rating for CVS, with several raising price targets, …
Arvest Bank Trust Division significantly increased its stake in CVS Health Corporation by 2,401.7% in the first quarter, now owning 66,945 shares worth $4.808 million. Other institutional investors like Vanguard Group Inc., State Street Corp, and Capital International Investors also increased their holdings. CVS …
CVS Health (CVS) recently closed at $110.60, outperforming the S&P 500's daily gain and demonstrating strong performance over the past month. The company is set to release its earnings on August 5, 2026, with anticipated EPS and revenue growth. CVS Health currently holds a …
Sharemaestro market context Trend signal active 52 weeks +20.8%The article "Why VSE Corporation (NASDAQ:VSEC) Could Be Worth Watching" provides an in-depth analysis of VSE Corporation's financial position and market performance. It includes details such as their debt levels, recent earnings, future outlook, and comparisons to industry peers. The assessment suggests VSEC might …
CVS Health Corp's stock has hit a new 52-week high of $108.97, reflecting strong investor confidence and an 81% total return over the past year. Despite its current valuation, InvestingPro analysis suggests the stock is undervalued with additional upside potential. Recent developments include a …
Dog and cat owners can now fill common pet prescriptions at all CVS Pharmacy locations nationwide WOONSOCKET, R.I., July 21, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that common prescription medications for dogs and cats are now available at its approximately 9,000 …
Sharemaestro market context Trend signal active 52 weeks +20.8%Commerzbank Aktiengesellschaft FI significantly increased its stake in CVS Health Corporation, purchasing an additional 47,646 shares in Q1, raising its total holdings to 102,099 shares valued at $7.33 million. This increase follows CVS Health's stronger-than-expected Q1 earnings, with EPS of $2.57 and revenue of …
Dimensional Fund Advisors LP significantly increased its stake in CVS Health Corporation by 3.0% in Q1 2026, bringing its total holdings to 7.2 million shares valued at $516.8 million. This increase follows CVS Health's strong first-quarter performance, where it exceeded EPS and revenue expectations …
Photo by kravaivan11 on Pixabay You may not have bought this single stock, but your funds quietly made it one of your biggest positions. CVS Health (CVS) stock has returned a striking +75% over the past year, and if you own common exchange-traded funds, …
Sharemaestro market context Trend signal active 52 weeks +20.8%The Swiss National Bank increased its stake in CVS Health Corporation by 7.2% in Q1, bringing its total holdings to 3.73 million shares valued at approximately $267.6 million. This comes as CVS reported strong quarterly results, beating revenue and EPS estimates, and issued a …
AIA Group Ltd significantly increased its stake in CVS Health Corporation by 104.8% in the first quarter, now owning 177,654 shares valued at $12.76 million. Other institutional investors also adjusted their positions in CVS Health, with hedge funds and institutional investors collectively owning 80.66% …
The article describes CVS Caremark Mail Service Pharmacy as a crucial business-to-business (B2B) engine for CVS Health Corp., handling millions of maintenance prescriptions primarily for employers and health plans in the United States. This service focuses on high-volume, automated mail dispensing of medications, aiming …
Morgan Stanley has reiterated its "Hold" rating for VSE Corp (VSEC.US) but has adjusted its target price downward to $230. This decision reflects the firm's updated outlook on the company's financial prospects, suggesting a maintained cautious stance despite the price target modification.
This article provides financial information for Kyivstar Group Ltd. (NASDAQ: KYIVW) with a focus on its price-to-book forward ratio. It highlights that the market was closed at the time of publication and no trades were recorded. The content functions as a financial data display …
VSE Corporation (VSEC) surpassed analyst expectations for Q4 2024, reporting an actual EPS of $0.90 against a consensus of $0.72, and actual revenue of $299.02 million compared to an expected $289.97 million. This marks a significant 27.07% year-over-year revenue growth. The company announced its …
CVS Health's stock has seen a significant increase over the past year, returning 74.4%. However, its current valuation, with a P/E ratio of 46.3x, is considered expensive compared to the Healthcare industry average of 25.5x and a fair P/E of 40.7x. The article suggests …
Versus Systems Inc. (Nasdaq: VS) held its annual meeting on July 16, 2026, where shareholders elected four directors and approved a proposal to adjourn the meeting if needed to solicit additional proxies. The company reported that 68.42% of eligible shares were present, with all …
Versus Systems (NASDAQ: VS) is strengthening its position in audience engagement with its Winfinite and Filter Fan Cam platforms, offering interactive games, real-world rewards, and augmented reality experiences. Zacks Investment Research has initiated coverage, noting improved first-quarter 2026 results and potential growth through its …
Kyivstar, VEON และกระทรวงเศรษฐกิจของยูเครนได้ลงนามในบันทึกความเข้าใจเพื่อพัฒนาศูนย์ข้อมูล Sovereign AI และโครงสร้างพื้นฐานดิจิทัลในประเทศยูเครน โครงการนี้มีเป้าหมายเพื่อเสริมสร้างศักยภาพด้าน AI ของยูเครนและสนับสนุนการฟื้นตัวทางเศรษฐกิจดิจิทัลของประเทศในระยะยาว. ความร่วมมือนี้จะช่วยส่งเสริมเทคโนโลยีดิจิทัลและนวัตกรรม AI เพื่อประโยชน์ของประชาชนและภาคธุรกิจ.
Wall Street Zen has downgraded CVS Health (NYSE:CVS) from "buy" to "hold," despite other analysts raising price targets and a generally positive outlook from a broader analyst pool. CVS Health reported strong quarterly results, exceeding both earnings and revenue expectations, but faces ongoing regulatory …
Sharemaestro market context Trend signal active 52 weeks +39.7%CVS Health closed at $104.2, only 1.9% below its 52-week peak, but the latest weekly move lacked volume confirmation and relative strength has cooled over four weeks.
Search by ticker symbol or company name and select a result to open its chart.